SEP 13, 2016 12:30 PM PDT

Defining Best Practices for Urinalysis Diagnostics in a Value-Based Healthcare System

Sponsored by: Arkray, Arkray
Speakers
  • Medical Director Core Laboratory & Laboratory Informatics, Laboratory Medicine
    Biography
      Dr. Skelton is a Board Certified Clinical Pathologist who received a BS from MIT and MD PhD degrees from Washington University in St. Louis. Residency & Fellowship training were completed at Massachusetts General Hospital. Dr. Skelton is a leader in the implementation of new approaches to the clinical practice of Laboratory Medicine that impact the economics and outcomes of patient care. He has combined his NIH-funded research, industry collaboration, and advanced information technology to develop lab-based algorithms that maximize an integrated healthcare system's ability to deliver high-quality low-cost patient care. Areas of expertise include Hematology, Coagulation, Cancer Biomarkers, Endocrinology, Critical Care, Urinalysis, and Chemistry. Dr. Skelton teaches a graduate course on Clinical Laboratory Quality in the Clinical Laboratory Sciences Department at University of Massachusetts Lowell.

    Abstract:
    Urinalysis is one the oldest, most established, and most frequently ordered laboratory tests.  However, there is wide variation in the methods, processes, quality checks, specifications, and diagnostic scope in clinical use today.  Dr. Skelton will describe his experience with a focused systematic effort to identify and implement best practices in all aspects of urinalysis testing at Lahey Health.  Decisions on best practice were made with the goal of optimizing clinical benefit to Lahey Health’s patient population and reducing the total healthcare cost attributable to the burden of diseases evaluated by urinalysis.  Changes to institutional policies combined with novel application of information technology were applied to overcome perceived regulatory obstacles to optimal evidence-based clinical practice.  Best practices for order design, result reporting, and data architecture and their impact on workflow efficiencies will be discussed.  Recent technical advances in instrumentation allow improved diagnostic abilities that enable a redesign of the laboratory process and clinical scope of urinalysis.  Data will demonstrate the impact that this type of redesign has had at Lahey Health. 
     
    Learning Objectives:
    After attending this session, participants will be able to:
    • 1 Understand the variables that impact the clinical diagnostic performance of urinalysis testing
    • 2 Identify key developments in instrumentation, information technology, and healthcare delivery that improve the value of urinalysis diagnostics

    Show Resources
    You May Also Like
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    FEB 26, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    NOV 18, 2019 7:00 AM PST
    C.E. CREDITS
    NOV 18, 2019 7:00 AM PST
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    AUG 27, 2019 9:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 9:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    Loading Comments...
    Show Resources